Bioinformatics Strategies for Translating Genome‐Wide Expression Analyses into Clinically Useful Cancer Markers
- 1 May 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1020 (1) , 32-40
- https://doi.org/10.1196/annals.1310.005
Abstract
The DNA microarray has revolutionized cancer research. Now, scientists can obtain a genome-wide perspective of cancer gene expression. One potential application of this technology is the discovery of novel cancer biomarkers for more accurate diagnosis and prognosis, and potentially for the earlier detection of disease or the monitoring of treatment effectiveness. Because microarray experiments generate a tremendous amount of data and because the number of laboratories generating microarray data is rapidly growing, new bioinformatics strategies that promote the maximum utilization of such data are necessary. Here, we describe a method to validate multiple microarray data sets, a Web-based cancer microarray database for biomarker discovery, and methods for integrating gene ontology annotations with microarray data to improve candidate biomarker selection.Keywords
This publication has 14 references indexed in Scilit:
- ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining PlatformPublished by Elsevier ,2014
- Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progressionProceedings of the National Academy of Sciences, 2004
- Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learningNature Medicine, 2003
- Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serumProceedings of the National Academy of Sciences, 2003
- ArrayExpress--a public repository for microarray gene expression data at the EBINucleic Acids Research, 2003
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate CancerJAMA, 2002
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancerProceedings of the National Academy of Sciences, 2001